当前位置:首页 - 行情中心 - 国邦医药(605507) - 财务分析 - 现金流量表

国邦医药

(605507)

  

流通市值:122.36亿  总市值:122.36亿
流通股本:7.82亿   总股本:7.82亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,555,907,413.351,074,684,487.884,518,457,388.913,548,798,584.27
  收到的税费返还91,527,078.1254,839,460.24174,583,174.26128,316,189.95
  收到其他与经营活动有关的现金38,931,372.5315,289,350.8687,228,732.2666,925,845.5
  经营活动现金流入小计2,686,365,8641,144,813,298.984,780,269,295.433,744,040,619.72
  购买商品、接受劳务支付的现金1,642,742,067.79627,595,780.073,042,877,825.082,453,822,341.5
  支付给职工以及为职工支付的现金345,169,569.06208,921,982.15638,152,231.21490,575,169.08
  支付的各项税费120,876,319.0161,074,436.51236,343,718.61195,722,975.86
  支付其他与经营活动有关的现金122,628,374.4354,044,578.17303,617,360.95198,409,764.58
  经营活动现金流出小计2,231,416,330.29951,636,776.94,220,991,135.853,338,530,251.02
  经营活动产生的现金流量净额454,949,533.71193,176,522.08559,278,159.58405,510,368.7
二、投资活动产生的现金流量:
  收回投资收到的现金6,544,601,689.63,381,307,277.0215,367,860,342.3511,204,886,910.37
  取得投资收益收到的现金8,101,583.261,922,655.44877,682.412,908,614.8
  处置固定资产、无形资产和其他长期资产收回的现金净额--24,102,978.1517,391,741.16
  投资活动现金流入小计6,552,703,272.863,383,229,932.4615,392,841,002.911,235,187,266.33
  购建固定资产、无形资产和其他长期资产支付的现金327,660,508.2291,488,235.6277,711,058.05267,111,860.66
  投资支付的现金6,375,759,138.893,385,000,00015,966,588,846.3911,480,494,000.27
  投资活动现金流出小计6,703,419,647.113,476,488,235.616,244,299,904.4411,747,605,860.93
  投资活动产生的现金流量净额-150,716,374.25-93,258,303.14-851,458,901.54-512,418,594.6
三、筹资活动产生的现金流量:
  取得借款收到的现金485,000,000325,000,0001,032,026,321.89912,045,385.23
  收到其他与筹资活动有关的现金--184,579,636.56-
  筹资活动现金流入小计485,000,000325,000,0001,216,605,958.45912,045,385.23
  偿还债务支付的现金405,320,000272,100,000813,790,675727,697,125.14
  分配股利、利润或偿付利息支付的现金339,987,769.286,806,260.44359,627,313.46349,819,137.69
  支付其他与筹资活动有关的现金159,906,318-166,135,966.05109,651,422.94
  筹资活动现金流出小计905,214,087.28278,906,260.441,339,553,954.511,187,167,685.77
  筹资活动产生的现金流量净额-420,214,087.2846,093,739.56-122,947,996.06-275,122,300.54
四、汇率变动对现金及现金等价物的影响-18,995,565.99-7,741,059.84-1,358,562.083,233,366.23
五、现金及现金等价物净增加额-134,976,493.81138,270,898.66-416,487,300.1-378,797,160.21
  加:期初现金及现金等价物余额1,117,884,263.741,117,884,263.741,534,371,563.841,534,371,563.84
  期末现金及现金等价物余额982,907,769.931,256,155,162.41,117,884,263.741,155,574,403.63
补充资料:
  净利润341,322,474.13-817,573,712.5-
  资产减值准备3,970,311.96-27,022,156.04-
  固定资产和投资性房地产折旧240,964,582.2-466,523,416.16-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧240,964,582.2-462,618,145.04-
    投资性房地产折旧--3,905,271.12-
  无形资产摊销5,445,256.1-11,095,559.27-
  长期待摊费用摊销234,994.86-469,989.72-
  处置固定资产、无形资产和其他长期资产的损失---24,812,057.81-
  固定资产报废损失1,648,970.48-7,668,385.37-
  公允价值变动损失-8,042,965.83--12,922,936.6-
  财务费用38,312,944.41-24,493,405.36-
  投资损失-7,060,366.3--16,992,661.8-
  递延所得税-5,534,940.19--7,811,431.25-
  其中:递延所得税资产减少-3,266,923.78--4,558,529.52-
    递延所得税负债增加-2,268,016.41--3,252,901.73-
  存货的减少-95,784,920.46--439,762,402.05-
  经营性应收项目的减少-313,931,561.23-258,279,703.95-
  经营性应付项目的增加246,565,078.68--562,844,945.01-
  其他2,878,165.48-6,354,189.82-
  现金的期末余额982,907,769.93-1,117,884,263.74-
  减:现金的期初余额1,117,884,263.74-1,534,371,563.84-
  现金及现金等价物的净增加额-134,976,493.81--416,487,300.1-
公告日期2026-08-012026-04-162026-03-282025-10-17
审计意见(境内)标准无保留意见
TOP↑